A systemic review of PET and biology in lung cancer.

Authors:
  • NONoboru Oriuchi
    Noboru Oriuchi
  • NSNoriaki Sunaga
    Noriaki Sunaga
  • TITamotsu Ishizuka
    Tamotsu Ishizuka
  • KSKimihiro Shimizu
    Kimihiro Shimizu
  • NYNobuyuki Yamamoto
    Nobuyuki Yamamoto

Abstract
Positron emission tomography imaging with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose ((18)F-FDG) has been established as a significant molecular imaging technique in the management of lung cancer. However, (18)F-FDG accumulation is not specific, therefore several other radiotracers targeting hypoxia, cell proliferation and amino acid metabolism have been developed for the imaging of human cancers. This review summarizes the current data on the correlation between the underlying molecular biology and tumor PET accumulation in lung cancer.

This publication has 68 references indexed in Scilit: